Articles tagged with Clinical Trials
A Phase 1 human clinical trial has begun testing a freeze-dried, temperature-stable formulation of the experimental tuberculosis (TB) vaccine candidate ID93. The trial aims to determine if the single-vial formulation of ID93 and adjuvant GLA-SE is as effective as previously tested two-vial combination in inducing an immune response.
A multi-site randomized controlled trial is enrolling patients with critical limb ischemia to compare treatment efficacy, functional outcomes, cost effectiveness, and quality of life. The BEST-CLI Trial seeks to overcome treatment bias by involving multidisciplinary CLI teams at participating sites.
Russian scientists developed advanced implants for the Ilizarov orthopedic system, which form part of the system's variation applied for lengthening and correcting deformities in children. The new implants reduced treatment terms by two times, accelerating bone regeneration and improving tissue density.
Researchers found that super-donors have stool rich in bacteria that enhance metabolism and can provide the necessary chemicals to restore gut balance. Fecal transplants from these 'super-donors' achieve clinical remission rates double those of other donors, offering new hope for treating a range of conditions.
Researchers in Leicester are investigating the use of antibiotics to treat certain types of severe asthma, a condition affecting 1 in 20 people with asthma. The study aims to identify patients with specific subtypes of severe asthma and test new oral treatments, including doxycycline and dexpramipexole.
A promising compound TTP399 targets glucokinase protein implicated in type 2 diabetes, improving glycemic control and reducing liver fat. Phase 2 clinical trial of 190 participants shows no adverse effects, paving way for potential new treatment options.
A study found that couples interventions for individuals with type 2 diabetes can reduce partners' diabetes distress and increase marital satisfaction. The intervention also improved diastolic blood pressure, but had no significant impact on weight loss or diet and activity behaviors.
A retrospective analysis found that genetic variations in the COMT gene affected whether vitamin E decreased or increased cancer risk in study participants. The results showed a significant impact of COMT variants on cancer rates among women taking vitamin E supplements.
The study will investigate the impacts of iron deficiency on infant brain development and physical growth. The trials aim to recruit over 6000 women and children in developing countries.
Researchers are developing a breath test to detect cancer at an early stage by analyzing volatile organic compounds in the breath. The PAN Cancer trial aims to identify patterns of VOCs that could indicate the presence of different types of cancer.
A clinical trial tested the effectiveness of topical antibiotic mupirocin in eliminating Staphylococcus aureus colonization in hospitalized infants. The study found that mupirocin is safe and highly effective in reducing SA infection, with over 90% of treated infants testing negative for SA after treatment.
A recent study published in the Journal of Clinical Oncology found that time to biochemical failure can be used as a surrogate endpoint for locally advanced prostate cancer treatment, reducing overall survival benefit by 6% compared to traditional endpoints. The analysis of NRG-RTOG 9202 clinical trial results showed significant associ...
Global supplies of Ac-225 are insufficient to meet growing demand for radiotherapy. Two production routes show promise, relying on irradiation of parent elements to increase yields.
A new therapy has shown 'very promising' initial results in improving the sight of people with Leber congenital amaurosis type 10 (LCA10), a severe inherited retinal disease. The therapy, QR-110, was injected into one eye and left untreated in the other, resulting in improved vision and restored levels of normal CEP290 protein in cells.
The Butantan Institute and MSD will exchange proprietary process information and clinical trial data, accelerating vaccine development. The partnership aims to create a tetravalent vaccine effective against all four dengue virus serotypes.
Researchers have made a significant breakthrough in understanding the mechanisms of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disorder. The study found that ezogabine treatment can reduce motor neuron excitability in ALS patients, suggesting a potential new therapy for the disease.
Recent studies at SABCS 2018 highlight radiation therapy's efficacy in treating breast cancer, with trials refining treatments to provide more options for patients. Accelerated partial breast irradiation has been shown to be non-inferior to traditional whole breast irradiation.
A randomized trial found that low-dose tamoxifen (5 mg/day) halved the risk of disease recurrence and new disease in women with DCIS, LCIS, and ADH. Treatment was well-tolerated without significant adverse events.
A large clinical trial found that black women with hormone-receptor positive breast cancer had a higher risk of recurrence and death compared to white women, even when treated equally. The study suggests biological differences may contribute to the disparity in outcomes.
Researchers found that self-sampling kits can improve cervical cancer detection among women not participating in screening programs. Studies showed that HPV tests based on PCR technology were just as accurate on self-samples as those taken by clinicians, but signal amplification-based tests were less effective.
Researchers have developed a gene therapy treatment that is reversing disease symptoms in two adults with Sickle Cell Anemia. The treatment, which uses reduced-intensity preconditioning, shows promise for transportability to resource-challenged parts of the world where SCA is most common.
Researchers at Dana-Farber Cancer Institute present positive results from clinical trials of CAR T-cell therapy and immunotherapy for patients with leukemia and lymphoma. The studies show that Yescarta provides durable benefit to lymphoma patients, while pembrolizumab achieves long-lasting responses in patients with an aggressive form ...
A new study highlights the effectiveness of CAR T-cell therapy in treating diffuse large B cell lymphoma patients. The real-world outcomes show that 81% of patients responded to the therapy with 58% having no detectable cancer after four months.
A daily hydroxyurea pill has been shown to improve health outcomes for young children with sickle cell anemia in resource-challenged sub-Saharan Africa. The treatment reduced rates of pain episodes, infections, malaria, transfusions, and death by significant margins.
Researchers have developed an effective monoclonal antibody treatment, lanadelumab, that can reduce the frequency of life-threatening swelling attacks in patients with hereditary angioedema. The treatment has shown a 90% reduction in attack rate and can be self-administered every two weeks.
Researchers have developed an ointment to counter the effects of brown recluse spider bites, which can cause skin necrosis and renal failure. The trial has started in Brazil with 240 participants, comparing the effects of the ointment with a placebo.
A new study from the University of Warwick demonstrates that digital versions of established measurements for assessing back pain are just as reliable and responsive. Patients can assess their own back pain using a mobile app on their phone or tablet as effectively as current paper methods.
A randomized, controlled trial is enrolling patients with confirmed Ebola virus disease in the Democratic Republic of Congo to compare mortality among those receiving three investigational drugs with a control group. The trial aims to establish the safety and efficacy of these treatments in a comprehensive response to combat Ebola.
Two clinical trials using botulinum toxin injections to suppress post-operative atrial fibrillation (POAF) showed promising results. Patients who received BTX injections during surgery had a sustained reduction in POAF incidence and overall burden over three years, accompanied by reduced hospitalization needs.
A clinical trial found that a minimally invasive treatment for retinal detachment resulted in better visual acuity and reduced visual distortion compared to traditional surgery. The procedure, called pneumatic retinopexy (PnR), also showed significant cost benefits for healthcare systems.
A randomised controlled trial found that gut-directed hypnotherapy delivered by psychologists was effective in relieving IBS symptoms, with benefits persisting at 9-month follow-up. Group hypnotherapy was as effective as individual sessions, potentially offering a new treatment option for IBS patients.
Researchers from the BrainGate consortium demonstrate a brain-computer interface that allows people with paralysis to navigate and interact with off-the-shelf tablet devices. Participants were able to perform various tasks, including messaging, browsing, and music playback, with accuracy and speed.
A new brain-computer interface (BCI) enables people with paralysis to directly operate an off-the-shelf tablet device by thinking about making cursor movements and clicks. The participants were able to navigate through various apps, browse music selections, search for videos on YouTube, and compose emails and chats with high accuracy.
A neuroimaging study reveals that the medial prefrontal cortex (mPFC) shows increased activity when patients are shown drug cues, indicating a potential target for addiction treatment. The study aims to develop a novel non-invasive therapy using transcranial magnetic stimulation (TMS) to modulate neural networks.
Researchers at UNIGE have identified tamoxifen, a breast cancer medication, as a potential treatment for myotubular myopathy, a genetic disease that causes muscle paralysis and death before two years of age. The molecule greatly reduces the progression of the disease and boosts life expectancy in animal models by a factor of seven.
Researchers developed a new AI method to evaluate treatment effectiveness in individual patients. The method uses causal Bayesian networks and was applied to obstructive sleep apnea treatment, showing reduced mortality rates by 5%.
A new 15-minute brain scan predicts damage with 98% accuracy, helping doctors assess the extent of newborn brain damage and plan for long-term development. The scan may also aid in developing new treatments for brain injury in babies.
Scientists are conducting a phase I clinical trial combining NK cell therapy with an immunocytokine to target children with relapsed/refractory neuroblastoma. The treatment aims to kill cancer cells in a less toxic way than conventional therapies.
A new subclass of compounds, dubbed geroneuroprotectors (GNPs), has been identified as potential AD drug candidates and slow the aging process in mice. The study suggests that these compounds could provide therapeutic benefits for Alzheimer's disease and other diseases associated with aging.
A randomized clinical trial found that an exercise intervention including resistance, balance, and walking exercises improved functional capacity scales at hospital discharge. The study showed benefits for cognitive status among older hospitalized patients.
The VITAL study found that omega-3 fatty acids reduced the risk of heart attacks, particularly among African American participants. Vitamin D supplements may also lower cancer deaths over time, with a significant 25% reduction in mortality rates observed after two years of treatment.
A new oral drug significantly reduced menstrual bleeding in over 90% of premenopausal women with fibroid tumors. Elagolix also prevented estrogen-deficiency induced side effects like hot flashes and bone loss when prescribed with hormone therapy.
The SWOG Cancer Research Network and The Hope Foundation for Cancer Research provide grant support to U.S. Department of Veterans Affairs medical centers to enroll veterans in cancer clinical trials. This program aims to create a sustainable national network of sites offering new treatment options through clinical trials.
The HiLo trial found no significant difference in recurrence rates between patients given a low radiation dose compared to the standard higher dose. This means patients with low-risk thyroid cancer can benefit from fewer side effects, long-term complications, and more convenient treatment options.
A clinical trial found that eating fish twice a week as part of a Mediterranean diet can significantly decrease lung inflammation in children with mild asthma. The study involved 64 children from Greece and showed improved lung function after six months.
A novel immunotherapy combining Hu5F9-G4 and rituximab has shown safety and promise in a phase-1 clinical trial for non-Hodgkin's lymphoma. Half of the 22 patients enrolled experienced a positive response, with eight going into complete remission.
Two studies found that minimally invasive radical hysterectomy is associated with higher recurrence rates and worse overall survival for women with early-stage cervical cancer. The findings have already changed care at MD Anderson Cancer Center and could impact surgical management of all women with early-stage disease.
The Society of Vascular and Interventional Neurology presents the latest clinical trials and breakthrough technology related to vacuum aspiration for removing blood clots in stroke patients. The results aim to improve the lives of stroke patients worldwide.
Researchers investigated alternative radiation therapy regimens for early-stage breast cancer patients. The trial found that fewer, larger individual doses of radiation led to similar adverse effects as conventional radiation therapy after 10 years.
The IASLC affirms the strength of evidence supporting lung cancer screening, reducing mortality by 26-61% in high-risk populations. The organization recommends implementing global lung cancer screening programs, incorporating multidisciplinary teams and best-practice smoking cessation.
The NRG Oncology clinical trial BR001 found that SBRT is safe for patients with 2 metastases or 3-4 metastases in specific locations, including peripheral lung and abdomen/pelvic. The study showed zero protocol-defined dose-limiting toxicities across evaluable anatomic locations.
A study examined long-term outcomes of midurethral mesh sling operations for stress urinary incontinence, finding that 3.3% of women had their slings removed and 4.5% underwent reoperations within nine years. The reasons for removal or reoperations were not disclosed.
A new study finds that motion sickness and cybersickness share similar symptoms, including nausea, dizziness, and fatigue. The researchers suggest that virtual reality technology could be used to diagnose and prevent motion sickness in high-risk professions.
A study by NRG Oncology found that short-term androgen-deprivation therapy (ADT) combined with radiotherapy improved overall survival for men with early stage prostate adenocarcinoma for up to 10.4 years. However, the benefits dissipated after 18 years.
A study highlights the existence of barriers to the inclusion of 12 to 25-year-olds in both adult and paediatric early phase clinical trials. The legal minimum age limit in Europe is 18 years, preventing young patients from participating in trials designed for their tumor type.
A nine-week course of adjuvant trastuzumab was associated with similar disease-free survival and lower risk of cardiac toxicity compared to a one-year course in patients with HER2-positive early breast cancer. A six-month course of trastuzumab was also shown to be cost-effective, with an average cost saving of nearly £10,000 per patient.
EDAS surgery reroutes brain arteries to create new pathways for blood and oxygen, significantly decreasing stroke recurrence rates by 9.6% compared to intensive medical management alone. The study's findings are promising for applying EDAS to severe atherosclerosis of the brain arteries.
Researchers at Cold Spring Harbor Laboratory have developed a new approach called Density Estimation using Field Theory (DEFT) to analyze small datasets, inspired by theoretical physics. The method fixes shortcomings of common statistical methods, providing more certainty in conclusions.
A pooled analysis of four UK randomised controlled clinical trials found significant differences in chemotherapy side-effects between men and women with oesophagogastric cancer. Women experienced higher rates of nausea and vomiting, diarrhoea, mouth ulceration, and hair loss compared to men.
A randomized controlled trial found that a nurse-led care approach with a treat-to-target strategy significantly lowered uric acid levels and reduced the risk of gout flares and tophi compared to usual care. The study suggests that educating patients and providing regular follow-up can improve treatment adherence and outcomes.